Michael Hofman, Director of Prostate Cancer Theranostics and Imaging Centre of Excellence (ProSTIC) at Peter MacCallum Cancer Centre, shared a post on X:
“New Frontiers in PSMA Radioligand Therapy
Is this the ‘hottest’ session at ASCO25 ??
VIOLET: First-in-human trial of Terbium-161
BULLSEYE: Lu-PSMA in oligo-metastatic disease
ENZA-p: Biomarkers
More posts featuring ASCO25.